 YARDLEY, Pa., Sept. 22, 2021 GLOBE NEWSWIRE -- Optinose NASDAQ:OPTN, a pharmaceutical company focused on patients treated by ear, nose and throat ENT and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the Cantor Virtual Global Healthcare Conference on September 28, 2021, at 8:40 a.m. ET. 